Dow Employees' Pension Plan Trust - Oct 28, 2022 Form 4 Insider Report for SeaStar Medical Holding Corp (ICU)

Role
10%+ Owner
Signature
Dow Employees' Pension Plan Trust, /s/ Robert Sparling, By: Robert Sparling, Trustee
Stock symbol
ICU
Transactions as of
Oct 28, 2022
Transactions value $
$0
Form type
4
Date filed
11/1/2022, 05:22 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICU Common Stock Award +4.15M 4.15M Oct 28, 2022 Direct F1
transaction ICU Common Stock Purchase +300K +7.23% 4.45M Oct 28, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICU Warrants (Right to Buy) Award +1.73K 1.73K Oct 28, 2022 Common Stock 1.73K $10.00 Direct F3, F4
transaction ICU Warrants (Right to Buy) Purchase +300K 300K Oct 28, 2022 Common Stock 300K $11.50 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 28, 2022, LMF Acquisition Opportunities, Inc., a Delaware corporation ("LMF"), consummated a business combination (the "Business Combination") by and among LMF, LMF Merger Sub, Inc., a Delaware corporation and directly wholly-owned subsidiary of LMF ("Merger Sub") and SeaStar Medical, Inc., a Delaware corporation ("SeaStar Medical"), pursuant to which SeaStar Medical merged with and into Merger Sub, with SeaStar Medical continuing as the surviving entity in the merger as a wholly-owned subsidiary of LMF, and with LMF changing its name to SeaStar Medical Holding Corporation ("SeaStar Medical Holdings"). As part of the Business Combination each share of SeaStar Medical stock was exchanged for 1.20321 shares of common stock of SeaStar Medical Holdings ("Common Stock").
F2 In a concurrent private placement in connection with the Business Combination, the Reporting Person acquired 300,000 shares of Common Stock and warrants to purchase 300,000 shares of Common Stock for an aggregate purchase price of $3,000,000.
F3 The warrants are fully exercisable.
F4 As part of the Business Combination, each SeaStar Medical warrant was exchanged for a warrant to purchase 1.20321 shares of Common Stock.
F5 The warrants are fully exercisable